2016年5月16日 星期一

上海东亚富豪大酒店 - 中国上海徐汇区

项目路演

国际合作

临床平台

产业投资

SEBP2016 S i n o - E u r o B i o Pa r t n e r i n g 中欧生物医药合作暨投融资大会

Sino-Euro BioPartnering (SEBP) is an annual event that proposes a cost-effective and tailor-made business platform for European SMEs to partner with leading local companies. Following the increasing demand from European SMEs for an effective partnering platform in China, SEBP was first launched in 2013 by G-Med Consulting and a network of European bioclusters and governmental organisations. SEBP benefits from an exclusive network of Chinese and European companies in the medical and pharmaceutical fields as well as the support of some influential associations.

Biotech, Pharma & Medtech

Industry Insight

Investment Guide in Europe

European SMEs Showcase

Effective Partnering Platform

Academic - Hospital - Industry

LINK SEBP OFFICIAL WEBSITE

SEBP2016 S i n o - E u r o B i o Pa r t n e r i n g 中欧生物医药合作暨投融资大会

16th May, 2016 Regal East Asia, Shanghai

SAVE THE DATE!

Partnership: Research – Clinician – Business –Investment

SEBP2015 Agenda

16 May, 2016, Monday

Agenda (Functional Hall, 2nd Floor) B2B Meetings

(Agenda (Functional Hall, 2nd Floor))

08h00 - 17h30 Registration

Ple

nary

sess

ion

Opening （Head of Xuhui District，Head Dept of Economy, Canton Basel-Stadt）

Keynote 1: “Translational medicine in Shanghai Zhongshan Hospital” President, Zhongshan Hospital Keynote 2: “Shanghai Fenglin Life Science Park－The perfect platform for innovation and development President, Shanghai Fenglin Life and Healthcare Group

Keynote 3: “The Basel Biomedical Experience sharing”

Health Minister, Basel Area Keynote 4: “Investment in European Life Science－in depth analysis by region” KPMG（Europe） Director

Coffee break

Showcase I

One to One （B2B）

8 projects

Moderator: GM, BaselArea China Business Platform

Lunch

13h30 - 15h00 Showcase II

One to One （B2B）

6 projects

Moderator: CEO，Swissnex

Panel Discussion 1：“How to best integrate the research-clinicians-industry”

Moderator Panelist

GM Shanghai Juke Life Science Park Deputy Managing Dirctor, Biowin GM, Roche（China） GM, J&J Innovation Center (China) CEO, Medgate

Coffee break

Showcase III

One to One （B2B）

6 projects

Moderator: Co-Chair, French Healthcare Alliance

17h00 - 17h40 Panel Discussion 2：“Cross border partnership and investment opportunities”

Moderator Panelist

VP and Global Head, Roche Partnering Asia & Emerging Markets Partner, Law Firm Partner, Venture Company General Manager, Local Pharmaceutical Company

17h30 Closing

EUROPEAN SMEs INTERESTS AT HEART

| Key topics:

|Showcase:

“Translational medicine in Shanghai Zhongshan Hospital”

“ Investment in Europe, in depth analysis by region”

LINK SEBP2016

PROGRAMME

“I attended SEBP 2013 in Shanghai: I had a very positive impression. In my opinion, it is the right place to meet the Chinese scientific community, to share opinions and business opportunities, which must then be consolidated in several separate meetings. However, the proactive and informal atmosphere is very productive, and is a great facilitator for the first contacts between different cultures and business styles. I consider the participation to SEBP a great opportunity and the right investment for companies willing to explore potential partnerships into China.”

Dr. Domenico Criscuolo

CEO Genovax (Italy)

“SEBP is a specialized partnering fair selecting specific spotlight topics of interest and which provides unique opportunity to share not only China market insights but also European biotech and medical company’s development and commercial focus. We did attend the conference several time, presenting our new products and technologies to Chinese potential partners specially during the roadshow. These presentations were often followed by B2B discussions and did initiate business opportunities. We do appreciate the conference and wish great success in the following years.”

Dr.Thierry Leclipteux CEO Coris BioConcept (Belgium)

“ How to best integrate the research-clinicians-industry”

“ The Basel biomedical experience sharing”

“ Cross border partnership and investment opportunties”

About twenty companies from Europe, Israel and China will present their projects and business interests, which cover biotech, IVD and medtech to over 200 experts from the industry and investment community

SEBP2016 Projects

info@sebp-china.com 欢迎参加 SEBP2016！

Country Sector Summary Interest

Switzerland Medical Device Brand generic orthopeadics and dental implant producers, including artificial joint, and spinal implants

M&A or equity investment, partnership

Switzerland Medical service One of the world leading telemedicine companies provides medical real time solutions for patients

Local partnership

Switzerland Medical Device A well eastablished dental implant company with wide range of orthopeadics products

Distributor

Germany Medical Device

A leading 3D biotechnology company – uses bioprinting and biomaterials technologies to commercialize unique biomedical products. In 2014-16. The company is launching a stream of proprietary products for dental & orthopedic applications with an attainable market of $3.8 billion. The company seeks $55 million capital to accelerate its growth plans.

Funding and partner

Singapore IVD New generation of PCR, which could shorten the reaction time to 5-10min. Funding and distributor

France Diagnostics A clinical stage ophthalmological device company building precise, non-contact tonometers based on a novel vibration technology for measuring intraocular pressure or eye pressure (IOP)

Funding and develpoment partner

France CRO

Provid Specific tools for human biomedical research. Introduces a variety of new solutions for academia, biotech companies and bio-pharmaceutical industry that are looking for innovative in vivo models of human biological mechanisms.

Clients and partner

UK Medical Device

Proprietary medical grade platform for “warm” liver organ transplant. First CE approved platform for use of normothermic full automated perfusion for liver organ maintenance of physiological temperature, pressures, flows, oxygenation + pH with blood at 37°C.

Funding and partner

Ireland Bio-materials

Innovative medical products meeting the unmet needs for the regeneration of bone and cartilage tissue. The company opened in 2012. Currently the company is now in full scale manufacturing at a certified ISO 13485 premises for its first two products – product 1 for bone regeneration and product 2 for cartilage regeneration.

Funding and partner

Netherlands Medical Device Unique non-invasive product to treat glaucoma. Selling in Europe and started the registration process with CFDA in 2014.

Strategic / financial investor

Israel Biotech

Red C is developing a scalable, cost effective production process for Red C Universal Red Cells (red cells that are ABO and other antigen free) that nullifies the introduction of potential pathogens and enables extended shelf life without refrigeration. Red C Universal Red Cells will dramatically improve meeting the world’s demand for life saving blood transfusions for the breadth of patient scenarios and environmental conditions

Funding and partner

Switzerland Medical Device

To improve bone surgery in terms of speed, safety, precision and functional cuts using pre-operative and navigation software, advanced robot and optomechanical technologies combined into a single device, a compact automated Computer Assisted and Robot-Guided Laser Osteotome (CARLO) to perform all forms of osteotomies in contact-free mode including craniomaxillofacial, orthopaedic, skullbase and dentoalveolar surgeries and dental implantology.

Funding

Switzerland Biotech

Company focuses on the discovery and development of innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibition for the treatment of cancer and inflammatory diseases. While mTOR is a clinically validated drug target, PI3K inhibition achieved proof of concept status in clinical Phase III. PIQUR has a secured patent space, has protected a large portion of relevant chemical space.

Partnership

UK IVD

A global medical diagnostics business with a long history in point-of-care testing and central laboratory manufacturing. The products have a hard earned reputation for ease of use, reliability and accuracy. The company core focus is the Point of Care market with over 80,000 hemoglobin, A1c, glucose and lactate analyzers in regular use in more than 100 countries running more than 50m tests every year.

Distribution or acquisition (sale)

Belgium IVD

a European pioneer since 1996 who develops, produces and markets high performance rapid diagnostic tests based on antigen detection of human infectious gastro-enteric and respiratory diseases and animal diseases, DNA detection of biomarkers and clinical molecular.

Distribution and partnership

More to come

…. …… …..

AN IDEAL PLATFORM FOR COLLABORATIONS

| Previous Chinese participants

| Previous European participants

SIMPLY MEET WITH THE BESTS

SINOPHARM • WISON • FOSUN PHARMA • KEHUA • BIOMABS • DIAN DIAGNOSTICS • CP GUOJIAN • SUNDIA • UPPER BIOTECH • FRONTAGE • SHENZHEN TIME BOLE • HISUN PHARMA • HD BIOSCIENCES • SHANGHAI PHARMA • 3SBIO • WUXI APPTEC • SHANGPHARMA • MINDRAY • TIGERMED • NUOKANG BIOPHARM • T-MAB • FOUNTAINVEST PARTNERS • HUA MEDECINE • AB MART • ORBIMED • MEDICILON • WALVAX • MICROPOT • OMAHA CAPITAL • SHANGHAI BIOCHIP • BAYCITY CAPITAL • DAAN GENE • BSK VENTURES • ASCENTAGE PHARMA • WONDFO • HUA PHARMA • GENOR BIOPHARMA • YANGTZE RIVER PHARMA • PIONEER PHARMA • LUYE PHARMA • KEYBAY • SIMCERE • HENGRUI MEDICINE • OSMUNDA • BEIXING CAPITAL • YUYUE • CHAI TAI TIANQING PHARMA • CROWNBIO • DT CAPITAL • EDDINGPARM • KINGMED DIAGNOSTICS • MORNINGSIDE • PHARMALEGACY • QIMING VENTURE • HENLIUS BIOTECH • ZERUN BIOTECH • CHINA GRAND • TASLY • WEGO • GREATER PACIFIC CAPITAL • FARMASINO • FOSUN DIAGNOSITICS …

• Distributors • Pharma • Investors

• Medtech / IVD • CMO/CRO • Biotech

SEBP2016 REGISTRATION

info@sebp-china.com We look forward to seeing you in

Shanghai in 2016!

Previous Sponsors

Supporting Organisations

Early Bird fee

(before 16th April) Regular fee

(after 16th April) On site

(16th May) Description

Conference pass

m Industry, Investor, Services 250 Euros * 300 Euros*

3000 RMB***

Conference pass gives access to keynote speeches, panel discussions, roadshow and partnering sessions. The conference also provides simultaneous translation, lunch & coffee break, one online matchmaking account

m Academic, Individual, Organisation

200 Euros* 250 Euros*

Company promotion opportunities

q Roadshow 250 Euros** 300 Euros** NA Present your project to the audience, 10 minutes (limited to one roadshow /company)

q Poster 120 Euros** 120 Euros** NA Have your poster visible to all the participants (the fee includes the printing cost)

* per person ** per company (in addition to the registration fee) *** Price per person, payable in RMB only To enjoy the early bird rate, please register and arrange the payment before the 16th of April. Registration site: www.sebp-china.com

Ho

tel

http://RegalHotel.com

Room （RMB） Free

Deluxe Room 900 Breakfast and Internet

Premier Room 1100 Breakfast and Internet

Executive Room 1,600 Breakfast and Internet

Deluxe suite Room 3,200 Breakfast and Internet

The leading 5-star Regal International East Asia Hotel, is ideally located in the exclusive Hengshan Road. With cafés, bars, exquisite shops and beautifully arranged gardens scattered along the boulevard, this tree-lined promenade stretches to the two ends of famous commercial and leisure centers - Xu Jia Hui and Huai Hai Road. And the prestigious diplomatic district is within walking distance from Shanghai's best dining, shopping, night life and entertainment venues. Our luxury Shanghai hotel comprises a total of 320 guest rooms. All our rooms are tastefully designed in a contemporary setting with hints of Oriental flair, offering guests tranquility and serenity in a relaxed environment.